RxDoctor Payments Data

Matthew Gevelinger

Urogynecology and Reconstructive Pelvic Surgery · Germantown, WINPI 1851747794

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 68.8% of it on its own, with 4 other manufacturers making up the rest. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in WI, where the typical reported total is $3,148.

$1,603in general payments, 2019–2025

Across 22 payments — averaging $72.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Axonics, Inc.$272
  • Medtronic$157
  • Medical Device Business Services, Inc.$42
  • Intuitive Surgical$29

What the payments were for

  • Food & beverage$1,603100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,603 in reported general payments places this provider in the 35th percentile of 25 urogynecology and reconstructive pelvic surgery providers in Wisconsin.

See all urogynecology and reconstructive pelvic surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$139,121
Medicare patients
195
Services billed
3,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron409$209,814
MyrbetriqMirabegron167$110,460
Estradiol218$14,556
Methenamine Hippurate102$6,672
Fosfomycin Tromethamine14$2,673
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst86$1,149
Trimethoprim26$1,043
Cephalexin94$670
Trospium Chloride12$317
Clobetasol Propionate13$301
Fluconazole25$286
Ciprofloxacin Hcl69$248
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim65$244
Ibuprofen13$64
Oxycodone Hcl14$17

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Germantown

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →